Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Nov:49:408-409.
doi: 10.1016/j.ajem.2021.02.011. Epub 2021 Feb 20.

Neuroleptic malignant syndrome following COVID-19 vaccination

Mostafa Alfishawy  1 , Zouheir Bitar  2 , Amr Elgazzar  2 , Mahmoud Elzoueiry  2
Affiliations
Comment

Neuroleptic malignant syndrome following COVID-19 vaccination

Mostafa Alfishawy et al. Am J Emerg Med. 2021 Nov.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Soh M, Hifumi T, Isokawa S, Shimizu M, Otani N, Ishimatsu S. Neuroleptic malignant syndrome in patients with COVID-19. Am J Emerg Med. 2020;38(10):2243.e1–2243.e3. - PMC - PubMed
    1. Kajani R., Apramian A., Vega A., et al. Neuroleptic malignant syndrome in a COVID-19 patient. Brain Behav Immun. 2020;88:28–29. - PMC - PubMed
    1. Ubhayakar N., Liu A. Letter to the editor: Neuroleptic malignant syndrome in COVID-19 patients by Soh et al [published online ahead of print, 2020 Jun 23] Am J Emerg Med. 2020 S0735–6757(20)30526-X. - PMC - PubMed
    1. Polack F.P., Thomas S.J., Kitchin N., et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020 Dec 31;383(27):2603–2615. - PMC - PubMed
    1. Castells M.C., Phillips E.J. Maintaining safety with SARS-CoV-2 Vaccines. N Engl J Med. 2021;384(7):643–649. - PMC - PubMed

Substances